Emily Cheney
Impact in
- Oncology top 10%
- PARP inhibition in cancer therapy
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Immunology top 10%
- interferon and immune responses
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 1
- CAR-T cell therapy research 1
-
- Religion, Society, and Development 1
- Co-authors
- Jennifer L. Guerriero (3 shared papers)Anita K. Mehta (2 shared papers)Jocelin Pinto (1 shared paper)Constantia Pantelidou (1 shared paper)Mateus de Oliveira Taveira (1 shared paper)Dan Wang (1 shared paper)Gerburg M. Wulf (1 shared paper)Peter Bouwman (1 shared paper)
- Journals
- Scientific Reports (1 paper)Cancer Discovery (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Breast Cancer Research (1 paper)
- Partner nations
- United StatesSwitzerlandNetherlands
In The Last Decade
Emily Cheney
5 papers receiving 598 citations
Emily Cheney's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 373
- Immunology 259
- Cancer Research 65
- Reproductive Medicine 28
- Molecular Biology 231
Countries citing papers authored by Emily Cheney
This map shows the geographic impact of Emily Cheney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Cheney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Cheney more than expected).
Fields of papers citing papers by Emily Cheney
This network shows the impact of papers produced by Emily Cheney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Cheney. The network helps show where Emily Cheney may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Cheney, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer Hit paper breakdown → | 2019 | 500 |
| 2 | 2018 | 56 | |
| 3 | 2019 | 30 | |
| 4 | 2021 | 16 | |
| 5 | She Can Read: Feminist Reading Strategies for Biblical Narrative | 1996 | 1 |
About Emily Cheney
Emily Cheney is a scholar working on Oncology, Sociology and Political Science, Religious studies, Cell Biology and Infectious Diseases, having authored 5 papers that have together received 603 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Biblical Studies and Interpretation (1 paper), Cancer Cells and Metastasis (1 paper), Pentecostalism and Christianity Studies (1 paper), Microtubule and mitosis dynamics (1 paper), Religion, Society, and Development (1 paper), Cellular Mechanics and Interactions (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (373 citations), Immunology (259 citations), Cancer Research (65 citations), Reproductive Medicine (28 citations) and Molecular Biology (231 citations). Emily Cheney has collaborated with scholars based in United States, Switzerland and Netherlands. Frequent co-authors include Jennifer L. Guerriero, Anita K. Mehta, Jocelin Pinto, Constantia Pantelidou, Mateus de Oliveira Taveira, Dan Wang, Gerburg M. Wulf, Peter Bouwman, Sven Rottenberg and Geoffrey I. Shapiro. Their work appears in journals such as Scientific Reports, Cancer Discovery, Journal for ImmunoTherapy of Cancer and Breast Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.